Breaking News

Laughter: just what the medical system ordered?

December 22, 2024
avatar-torie-bosch
First Opinion editor

We have almost made it to the new year. Whether you'll be working, celebrating, both, or neither over the next two weeks, I hope that you get to enjoy some peace and warmth. I for one will both work and celebrate. Are you one of the approximately 8,000 people to whom I owe an edit of a First Opinion essay? If so, please know that I hope to use the relatively quiet last two weeks of the year to edit it.

A few weeks back, I asked you to share 1) what stories you thought had gone underexplored in health/medicine/biopharma this year and 2) what you expect from 2025. I was so pleased to get a massive response from a wide range of readers. This coming week, I'll publish many of those reactions on STAT.

On Wednesday, the last episode of this season of the "First Opinion Podcast" came out. I spoke with Will Flanary, aka Dr. Glaucomflecken, about his approach to medical comedy — but also about the societal response to the shooting of UnitedHealthcare CEO Brian Thompson. Flanary told me that he finds it difficult to scold people for their emotional reactions when he knows how much the insurance system has both literally and figuratively hurt people. He hopes to continue to use comedy to spotlight the ways the system fails patients (and health care practitioners). I too love to use humor in a space where it can be hard to find — if you have an idea for a funny First Opinion, email me: first.opinion@statnews.com. The podcast will return in the spring, and I'm eager for your thoughts on what we should do to mix up the show.

This newsletter will be on hold next week, but we'll be back again in 2025. Happy holidays!

And in the meantime: I'd love to hear what low-stakes opinions cause the most chaos at your holiday tables. Please tell me who argued about drones, what music to listen to, or anything else that ends up becoming a symbol of something much bigger.

Recommendation of the week: I'm a wholly secular Christmas celebrant. But there are 90 minutes of the holiday season I hold sacred: my annual Christmas Eve viewing of "Muppet Christmas Carol."

Adobe

The 'skin in the game' approach to health care spending has failed

If we want a humane health care system that delivers better outcomes, we must design payment policies that serve patients, not the insurance industry.

By Merrill Goozner


Gene therapy trials should emphasize transparency, not secrecy

Two recent deaths in gene therapy trials demonstrate that the industry needs to take a new approach to data sharing.

By Rafael Escandon and Arthur L. Caplan


STAT+ | AI's dangerous mental-health blind spot

Study finds chatbots were unable to reliably detect mental health emergencies, offered harmful information to users having symptoms of mania or psychosis.

By Declan Grabb and Max Lamparth



Dr. Glaucomflecken uses humor to spotlight the darkness in medicine

Will Flanary, aka Dr. Glaucomflecken, on using comedy to trick people into caring about the health care system.

By Torie Bosch


The DRC 'mystery illness' shows why the U.S. can't 'pause' infectious disease work

Continued U.S. investment in global health security is not just altruism; it is a strategic necessity that keeps us all safer.

By Craig Spencer and Nahid Bhadelia


A key to Black Americans' health may lie in a misunderstanding of the slave trade

I have a theory about the slave trade, Black Americans, salt, and kidney disease. Why won't anyone listen?

By Constance B. Hilliard


Adobe

STAT+ | Pharmacy benefits managers should be worried

As a former FTC policy director, I think the new Trump administration is going to finish off the PBM reform begun during his first presidency.

By David Balto


STAT+ | How AI can help bring better care to Medicaid patients

Many Medicaid patients have fragmented, disorganized records that make it hard to provide them care. Carefully designed AI can help.

By Sadiq Y. Patel


My oral cancer shows the deep connections between chronic and infectious disease

MAHA wants to separate infectious disease and chronic disease research. But the two are inseparable, as demonstrated by the HPV-cancer connection.

By Larry Schlesinger


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments